Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0162871 (
abdominal aortic aneurysm
)
8,664
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Deficits in mitochondrial function result in many human diseases. The X-linked disease
Barth syndrome
(
BTHS
) is caused by mutations in the tafazzin gene TAZ1. Its product, Taz1p, participates in the metabolism of cardiolipin, the signature phospholipid of mitochondria. In this paper, a yeast
BTHS
mutant tafazzin panel is established, and 18 of the 21 tested
BTHS
missense mutations cannot functionally replace endogenous tafazzin. Four
BTHS
mutant
tafazzins
expressed at low levels are degraded by the intermembrane space
AAA
(i-AAA) protease, suggesting misfolding of the mutant polypeptides. Paradoxically, each of these mutant
tafazzins
assembles in normal protein complexes. Furthermore, in the absence of the i-AAA protease, increased expression and assembly of two of the
BTHS
mutants improve their function. However, the
BTHS
mutant complexes are extremely unstable and accumulate as insoluble aggregates when disassembled in the absence of the i-AAA protease. Thus, the loss of function for these
BTHS
mutants results from the inherent instability of the mutant tafazzin complexes.
...
PMID:Barth syndrome mutations that cause tafazzin complex lability. 2130 Aug 50